EDN1 and pulmonary arterial hypertension: The active role of ET-1 in the development of pulmonary hypertension is further supported by studies that have shown inhibition and even reversal of pulmonary hypertension in chronically hypoxic animals treated with ETA-receptor antagonists [23], [25], [27], [28], [68], [69].